Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCADOL II: MEOPA + Paracetamol vs Morphine in STEMI
NCT02198378Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Nov 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of nitrous oxide and acetaminophen in acute coronary syndrome (ACS) (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Effective analgesia (NRS score <= 3) at 30 months. Started Nov 2014; status: completed.
02
Drugs
nitrous oxideacetaminophen
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02198378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198378.